9-92715207-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 1P and 7B. PP2BP4_ModerateBP6BS2
The NM_001003800.2(BICD2):c.2515G>A(p.Gly839Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000391 in 1,611,862 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001003800.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BICD2 | NM_001003800.2 | c.2515G>A | p.Gly839Arg | missense_variant | 7/7 | ENST00000356884.11 | NP_001003800.1 | |
BICD2 | NM_015250.4 | c.2469+46G>A | intron_variant | NP_056065.1 | ||||
BICD2 | XM_017014551.2 | c.2550+46G>A | intron_variant | XP_016870040.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BICD2 | ENST00000356884.11 | c.2515G>A | p.Gly839Arg | missense_variant | 7/7 | 1 | NM_001003800.2 | ENSP00000349351 | A2 | |
BICD2 | ENST00000375512.3 | c.2469+46G>A | intron_variant | 1 | ENSP00000364662 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152248Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000281 AC: 7AN: 249100Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 134956
GnomAD4 exome AF: 0.0000391 AC: 57AN: 1459614Hom.: 0 Cov.: 32 AF XY: 0.0000344 AC XY: 25AN XY: 725858
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152248Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74386
ClinVar
Submissions by phenotype
Spastic paraplegia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Paris Brain Institute, Inserm - ICM | - | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 18, 2022 | The p.G839R variant (also known as c.2515G>A), located in coding exon 7 of the BICD2 gene, results from a G to A substitution at nucleotide position 2515. The glycine at codon 839 is replaced by arginine, an amino acid with dissimilar properties. This alteration has been detected in two siblings with lower extremity-predominant spinal muscular atrophy 2 (SMALED2) and a family history of relatives with similar clinical features (Rudnik-Schöneborn S et al. Muscle Nerve, 2016 09;54:496-500). This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Autosomal dominant childhood-onset proximal spinal muscular atrophy with contractures Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 15, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at